Letter to the Editor Regarding “Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in Current and Investigational Pneumococcal Conjugate Vaccines in Children Under Five Years of Age”
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2193-6382
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Letter to the Editor Regarding “Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in Current and Investigational Pneumococcal Conjugate Vaccines in Children Under Five Years of Age” ; volume:12 ; number:1 ; day:14 ; month:11 ; year:2022 ; pages:291-294 ; date:1.2023
Infectious diseases and therapy ; 12, Heft 1 (14.11.2022), 291-294, 1.2023
- Urheber
-
Feemster, Kristen
Weiss, Thomas
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40121-022-00718-5
- URN
-
urn:nbn:de:101:1-2023033021073211292207
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Feemster, Kristen
- Weiss, Thomas
- SpringerLink (Online service)
Ähnliche Objekte (12)
Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in Current and Investigational Pneumococcal Conjugate Vaccines in Children Under Five Years of Age
Reanalysis of the Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in Current and Investigational Pneumococcal Conjugate Vaccines in Children < 5 Age: A Societal Perspective
A Response to: Letter to the Editor Regarding ‘Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in Current and Investigational Pneumococcal Conjugate Vaccines in Children Under Five Years of Age’
Estimates of the Health and Economic Burden of Pneumococcal Infections Attributable to the 15-Valent Pneumococcal Conjugate Vaccine Serotypes in the USA
Correction to: Estimates of the Health and Economic Burden of Pneumococcal Infections Attributable to the 15-Valent Pneumococcal Conjugate Vaccine Serotypes in the USA
A longitudinal analysis of pneumococcal vaccine serotypes in pneumonia patients in Germany
A longitudinal analysis of pneumococcal vaccine serotypes in pneumonia patients in Germany
A longitudinal analysis of pneumococcal vaccine serotypes in pneumonia patients in Germany
Invasive pneumococcal infections in Vellore, India: clinical characteristics and distribution of serotypes
Invasiveness potential of pneumococcal serotypes in children after introduction of PCV13 in Blantyre, Malawi
Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease
Serologic response to pneumococcal vaccination in children experiencing recurrent invasive pneumococcal disease
Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in Current and Investigational Pneumococcal Conjugate Vaccines in Children Under Five Years of Age
Reanalysis of the Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in Current and Investigational Pneumococcal Conjugate Vaccines in Children < 5 Age: A Societal Perspective
A Response to: Letter to the Editor Regarding ‘Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in Current and Investigational Pneumococcal Conjugate Vaccines in Children Under Five Years of Age’
Estimates of the Health and Economic Burden of Pneumococcal Infections Attributable to the 15-Valent Pneumococcal Conjugate Vaccine Serotypes in the USA
Correction to: Estimates of the Health and Economic Burden of Pneumococcal Infections Attributable to the 15-Valent Pneumococcal Conjugate Vaccine Serotypes in the USA
A longitudinal analysis of pneumococcal vaccine serotypes in pneumonia patients in Germany
A longitudinal analysis of pneumococcal vaccine serotypes in pneumonia patients in Germany
A longitudinal analysis of pneumococcal vaccine serotypes in pneumonia patients in Germany
Invasive pneumococcal infections in Vellore, India: clinical characteristics and distribution of serotypes
Invasiveness potential of pneumococcal serotypes in children after introduction of PCV13 in Blantyre, Malawi
Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease
Serologic response to pneumococcal vaccination in children experiencing recurrent invasive pneumococcal disease
Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in Current and Investigational Pneumococcal Conjugate Vaccines in Children Under Five Years of Age
Reanalysis of the Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in Current and Investigational Pneumococcal Conjugate Vaccines in Children < 5 Age: A Societal Perspective
A Response to: Letter to the Editor Regarding ‘Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in Current and Investigational Pneumococcal Conjugate Vaccines in Children Under Five Years of Age’
Estimates of the Health and Economic Burden of Pneumococcal Infections Attributable to the 15-Valent Pneumococcal Conjugate Vaccine Serotypes in the USA
Correction to: Estimates of the Health and Economic Burden of Pneumococcal Infections Attributable to the 15-Valent Pneumococcal Conjugate Vaccine Serotypes in the USA
A longitudinal analysis of pneumococcal vaccine serotypes in pneumonia patients in Germany
A longitudinal analysis of pneumococcal vaccine serotypes in pneumonia patients in Germany
A longitudinal analysis of pneumococcal vaccine serotypes in pneumonia patients in Germany
Invasive pneumococcal infections in Vellore, India: clinical characteristics and distribution of serotypes
Invasiveness potential of pneumococcal serotypes in children after introduction of PCV13 in Blantyre, Malawi
Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease